{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:36:09Z","timestamp":1780734969885,"version":"3.54.1"},"reference-count":15,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/jcpt.12373","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T04:56:33Z","timestamp":1456980993000},"page":"116-118","source":"Crossref","is-referenced-by-count":20,"title":["Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database"],"prefix":"10.1155","volume":"41","author":[{"given":"V.","family":"Pizzimenti","sequence":"first","affiliation":[{"name":"Department of Clinical Biomedical and Dental Sciences and Morpho-functional Imaging; University of Messina; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giandalia","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cucinotta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. T.","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine; University of Messina; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smits","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Diabetes Center; VU University Medical Center; Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Cutroneo","sequence":"additional","affiliation":[{"name":"Sicilian Regional Centre of Pharmacovigilance; Clinical Pharmacology Unit -AOU Policlinico \u201cG. Martino\u201d; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Trifir\u00f2","sequence":"additional","affiliation":[{"name":"Department of Clinical Biomedical and Dental Sciences and Morpho-functional Imaging; University of Messina; Messina Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"10.1111\/jcpt.12373-BIB0001|jcpt12373-cit-0001","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1111\/jcpt.12373-BIB0002|jcpt12373-cit-0002","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.diabres.2015.10.014","article-title":"Incretin-based therapies are associated with acute pancreatitis: meta-analysis of large randomized controlled trials","volume":"110","author":"Roshanov","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jcpt.12373-BIB0003|jcpt12373-cit-0003","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-014-0223-0","article-title":"Extra-pancreatic effects of incretin-based therapies","volume":"47","author":"Gallwitz","year":"2014","journal-title":"Endocrine"},{"key":"10.1111\/jcpt.12373-BIB0004|jcpt12373-cit-0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2012.08.005","article-title":"Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects","volume":"179","author":"Keller","year":"2012","journal-title":"Regul Pept"},{"key":"10.1111\/jcpt.12373-BIB0005|jcpt12373-cit-0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40520-015-0335-2","article-title":"Liraglutide-related cholelithiasis","volume":"27","author":"Korkmaz","year":"2015","journal-title":"Aging Clin Exp Res"},{"key":"10.1111\/jcpt.12373-BIB0006|jcpt12373-cit-0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12373-BIB0007|jcpt12373-cit-0007","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/0976-500X.162016","article-title":"Acalculous pyelonephritis and cholecystitis occurring simultaneously in a diabetic patient on sitagliptin therapy","volume":"6","author":"Sahoo","year":"2015","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1111\/jcpt.12373-BIB0008|jcpt12373-cit-0008","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.numecd.2014.07.014","article-title":"Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry","volume":"24","author":"Montilla","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/jcpt.12373-BIB0009|jcpt12373-cit-0009","first-page":"241","article-title":"Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4328 patients","volume":"8","author":"MacConell","year":"2015","journal-title":"Diabet Metabol Syndr Obes"},{"key":"10.1111\/jcpt.12373-BIB0010|jcpt12373-cit-0010","doi-asserted-by":"crossref","first-page":"279530","DOI":"10.1155\/2011\/279530","article-title":"Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function","volume":"2011","author":"Marathe","year":"2011","journal-title":"Exp Diabet Res"},{"issue":"Suppl. 3","key":"10.1111\/jcpt.12373-BIB0011|jcpt12373-cit-0011","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1590-8658(03)00088-4","article-title":"Factors affecting gallbladder motility: drugs","volume":"35","author":"Marzio","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1111\/jcpt.12373-BIB0012|jcpt12373-cit-0012","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/003655201750422710","article-title":"Effect of circulating peptide YY on gallbladder emptying in humans","volume":"36","author":"Hoentjen","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/jcpt.12373-BIB0013|jcpt12373-cit-0013","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10620-012-2455-2","article-title":"Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis","volume":"58","author":"Ben-Shlomo","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1111\/jcpt.12373-BIB0014|jcpt12373-cit-0014","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1196\/annals.1423.042","article-title":"Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses","volume":"1110","author":"Reinhold","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/jcpt.12373-BIB0015|jcpt12373-cit-0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/dc10-1771","article-title":"Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase","volume":"34","author":"Willemen","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12373","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12373","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12373\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:06:16Z","timestamp":1671818776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12373","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}